Nuo Therapeutics, Inc. entered into a securities purchase agreement with certain accredited investors for issuance of 517,500 common shares at a price of $2 per share for gross proceeds of $1,035,000 on July 26, 2023. The common shares have a par value $0.0001 per share. The transaction included participation from 9 investors including new investors Scott M. Pittman, a member of the board of directors of the company for $200,000; Peter A. Clausen, the Chief Scientific Officer and Chief Operating Officer of the company for $50,000; and Charles E. Sheedy, a principal stockholder of the company for $125,000.

The common shares were offered and sold pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 thereunder, in a transaction not involving any public offering. The company will issue securities pursuant to exemption provided under Regulation D.